Amendment 001_2031ZA24Q00023_WCF Drug Testing Services.pdf

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER

NUMBER IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

The purpose of Amendment 001 is to include: 1) Questions/Responses, 2) Updated solicitation 2031ZA24Q00023, and 3) Attachment 4 - BPA Terms and Conditions.

All offerors must acknowledge the amendment in accordance with the instructions in Block 11 on Standard Form 30.

The proposal due date of April 30, 2024 at 12:00PM CST remains unchanged and in full force and effect.

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

16C. DATE SIGNED

Previous edition unusable STANDARD FORM 30 (REV. 11/2016) Prescribed by GSA FAR (48 CFR) 53.243

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

2. AMENDMENT/MODIFICATION NUMBER

PAGE OF PAGES

5. PROJECT NUMBER (If applicable)

6. ISSUED BY CODE 2031ZA 7. ADMINISTERED BY (If other than Item 6) CODE

BEP-ACQUISITION

Bureau of Engraving and Printing, Office of Acquisition, 301 14th Street SW Washington, DC, 20228-0001, US

8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) 9A. AMENDMENT OF SOLICITATION NUMBER

2031ZA24Q00023

9B. DATED (SEE ITEM 11)

04/11/2024

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED (SEE ITEM 13)

CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

FACILITY CODE

(X)

4. REQUISITION/PURCHASE REQUISITION NUMBER 3. EFFECTIVE DATE

04/22/2024

1. CONTRACT ID CODE

1 2

Bureau of Engraving and Printing (BEP)/ Western Currency Facility (WCF) Questions/Responses

Solicitation: 2031ZA24Q00023 Drug Testing Services

Question 1: Subject: RFQ No. 2031ZA24Q00023; Reference: RFQ , Paragraph(s) Page(s)

Is there an Incumbent lab currently conducting this testing, or is this a new requirement? If there is, can the government share the award number in order to review pricing and scope of work.

Response: The incumbent contractor is Comprehensive Drug Testing, Inc. The Blanket Purchase Agreement (BPA) 2031ZA19A00010 was awarded as a shall not exceed $231,150.00 for the entire term of the BPA (five (5) one year ordering periods) for the BEP in Washington, DC (DCF) and Fort Worth, Texas (WCF).

Question 2: Subject: RFQ No. 2031ZA24Q00023; Reference: RFQ Section Instructions to offerors, Paragraph(s) 2.2 & 2.3, Page(s) 17 & 18.

2.2 Submission process chart lists Volume I, Factor 1: Technical Approach, Factor 2: Experience Factor and 3: Key Personnel Volume II, Price. However, 2.3 General format, shows Volumes I, Technical and Volume II, Past Performance and states that NO price date shall be included.

Response: The solicitation has been updated under 2.3 General format to include Volume II, Price.

Question 3: Subject: RFQ No. 2031ZA24Q00023; Reference: RFQ Supplies or services and prices , Paragraph(s) CLIN, Page(s) 5.

Can the government please elaborate on the requirement for Non-negative test Management and Litigation package.

Response: The non-negative test management is a processing fee for when the lab has to work a positive drug test. This fee occurs when an employee or applicant fails a drug test. The litigation package is a detailed lab report for when an employee fails a drug test. If an employee fails a drug test management has the Government contact the testing contractor to request this lab report.